Stem Cell Reports · 2015 · 395 citations · 29 references
MedicineOphthalmologyVision ScienceCell TherapyRegenerative MedicineStem Cell BiotechnologyAge-related Macular DegenerationEmbryonic Stem CellsMacular DegenerationMacular DiseaseRetinal DegenerationRetinal Pigment EpitheliumEctopic Tissue FormationHuman Embryonic Stem CellsPluripotent Stem Cell DifferentiationPluripotent Stem Cell SafetyRetinal Pigment Epithelium DegenerationRetinal Pigment Epithelium DifferentiationRetinal Pigment Epithelium Stem CellsVisual Acuity Gains
Embryonic stem cells promise regenerative therapy, yet safety and efficacy in Asian patients remain unreported. The study reports safety and tolerability of subretinal transplantation of hESC‑derived retinal pigment epithelium in four Asian patients with dry age‑related macular degeneration or Stargardt macular dystrophy. Four patients received subretinal hESC‑derived RPE transplants and were followed for one year. No adverse proliferation, tumorigenicity, or ectopic tissue formation was observed, and visual acuity improved 9–19 letters in three patients while remaining stable in one, confirming the potential safety of hESC‑derived RPE.
Embryonic stem cells hold great promise for various diseases because of their unlimited capacity for self-renewal and ability to differentiate into any cell type in the body. However, despite over 3 decades of research, there have been no reports on the safety and potential efficacy of pluripotent stem cell progeny in Asian patients with any disease. Here, we report the safety and tolerability of subretinal transplantation of human embryonic-stem-cell (hESC)-derived retinal pigment epithelium in four Asian patients: two with dry age-related macular degeneration and two with Stargardt macular dystrophy. They were followed for 1 year. There was no evidence of adverse proliferation, tumorigenicity, ectopic tissue formation, or other serious safety issues related to the transplanted cells. Visual acuity improved 9–19 letters in three patients and remained stable (+1 letter) in one patient. The results confirmed that hESC-derived cells could serve as a potentially safe new source for regenerative medicine.
29
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Albert M. Maguire, Francesca Simonelli, Eric A. Pierce et al. · New England Journal of Medicine · 2008 · 2.1K citations · Full text
Medicine, Genetics, Ophthalmology +17
Embryonic stem cell trials for macular degeneration: a preliminary report
Steven D. Schwartz, Jean‐Pierre Hubschman, Gad Heilwell et al. · The Lancet · 2012 · 1.4K citations
Steven D. Schwartz, Carl D. Regillo, Byron L. Lam et al. · The Lancet · 2014 · 1.3K citations